RESUMO
Human colorectal cancer (CRC) is a major cause of cancer mortality and frequently harbors activating mutations in the KRAS gene. To understand the role of oncogenic KRAS in CRC, we engineered a mouse model of metastatic CRC that harbors an inducible oncogenic Kras allele (Krasmut ) and conditional null alleles of Apc and Trp53 (iKAP). The iKAP model recapitulates tumor progression from adenoma through metastases. Whole-exome sequencing revealed that the Krasmut allele was heterogenous in primary tumors yet homogenous in metastases, a pattern consistent with activated Krasmut signaling being a driver of progression to metastasis. System-level and functional analyses revealed the TGF-ß pathway as a key mediator of Krasmut -driven invasiveness. Genetic extinction of Krasmut resulted in specific elimination of the Krasmut subpopulation in primary and metastatic tumors, leading to apoptotic elimination of advanced invasive and metastatic disease. This faithful CRC model provides genetic evidence that Krasmut drives CRC invasion and maintenance of metastases.
Assuntos
Neoplasias Colorretais/genética , Neoplasias Colorretais/fisiopatologia , Invasividade Neoplásica/genética , Proteínas Proto-Oncogênicas p21(ras)/metabolismo , Animais , Linhagem Celular Tumoral , Modelos Animais de Doenças , Genótipo , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Mutação , Metástase Neoplásica , Proteínas Proto-Oncogênicas p21(ras)/genética , Transcriptoma , Fator de Crescimento Transformador beta/genética , Fator de Crescimento Transformador beta/metabolismoRESUMO
PURPOSE: We applied whole-genome sequencing (WGS) to children diagnosed with neoplasms and found to carry apparently balanced constitutional translocations to discover novel genic disruptions. METHODS: We applied the structural variation (SV) calling programs CREST, BreakDancer, SV-STAT, and CGAP-CNV, and we developed an annotative filtering strategy to achieve nucleotide resolution at the translocations. RESULTS: We identified the breakpoints for t(6;12)(p21.1;q24.31), disrupting HNF1A in a patient diagnosed with hepatic adenomas and maturity-onset diabetes of the young (MODY). Translocation as the disruptive event of HNF1A, a gene known to be involved in MODY3, has not been previously reported. In a subject with Hodgkin lymphoma and subsequent low-grade glioma, we identified t(5;18)(q35.1;q21.2), disrupting both SLIT3 and DCC, genes previously implicated in both glioma and lymphoma. CONCLUSION: These examples suggest that implementing clinical WGS in the diagnostic workup of patients with novel but apparently balanced translocations may reveal unanticipated disruption of disease-associated genes and aid in prediction of the clinical phenotype.
Assuntos
Estudos de Associação Genética , Genoma Humano , Sequenciamento de Nucleotídeos em Larga Escala , Neoplasias/genética , Translocação Genética , Adenoma/diagnóstico , Adenoma/genética , Adulto , Fatores Etários , Sequência de Bases , Criança , Pré-Escolar , Pontos de Quebra do Cromossomo , Cromossomos Humanos Par 12 , Cromossomos Humanos Par 18 , Cromossomos Humanos Par 5 , Cromossomos Humanos Par 6 , Receptor DCC , Variações do Número de Cópias de DNA , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/genética , Feminino , Genômica , Humanos , Mutação INDEL , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/genética , Masculino , Proteínas de Membrana/genética , Dados de Sequência Molecular , Neoplasias/diagnóstico , Polimorfismo de Nucleotídeo Único , Receptores de Superfície Celular/genética , Proteínas Supressoras de Tumor/genéticaRESUMO
Traumatic experiences can impact individuals' oral health and how they experience dental treatment in ways patients and their dental providers may or may not initially anticipate. As approximately half of children and two-thirds of adults in the United States have experienced some type of traumatic event, it is critically important for providers to be aware of patients' trauma histories and to appropriately provide trauma-informed care to their patients when needed. Individuals with a trauma history may experience significant anxiety and distress in the dental setting, even for treatment many providers and patients consider to be "simple," such as a brief intraoral examination, radiographs, or prophylaxis. Such aspects of the dental setting may trigger memories and emotions related to the original trauma and may re-traumatize patients. This short report introduces links between traumatic history, poor oral health, and dental care-related fear and anxiety. Additionally, this paper briefly describes how dental hygienists can provide compassionate trauma-informed care to their patients with the goal of providing whole-person care that considers patients' comfort, health goals, and prior experiences. Specific recommendations for providing trauma-informed care to children and adults within the scope of dental hygiene practice are provided, as is suggested wording for acknowledging a patient's prior trauma and tailoring dental care to accommodate patient experiences and concerns. As dental hygienists are often the oral health providers spending the most time with patients, they are uniquely positioned to provide compassionate effective trauma-informed care to patients with past traumatic experiences.
Assuntos
Ansiedade ao Tratamento Odontológico , Higienistas Dentários , Saúde Bucal , Humanos , Higienistas Dentários/psicologia , Ansiedade ao Tratamento Odontológico/psicologia , Ansiedade ao Tratamento Odontológico/prevenção & controle , Assistência Odontológica/psicologia , Adulto , Papel Profissional , CriançaRESUMO
BACKGROUND: The cellular response to DNA damage is immediate and highly coordinated in order to maintain genome integrity and proper cell division. During the DNA damage response (DDR), the sensor kinases Tel1 and Mec1 in Saccharomyces cerevisiae and ATM and ATR in human, phosphorylate multiple mediators which activate effector proteins to initiate cell cycle checkpoints and DNA repair. A subset of kinase substrates are recognized by the S/T-Q cluster domain (SCD), which contains motifs of serine (S) or threonine (T) followed by a glutamine (Q). However, the full repertoire of proteins and pathways controlled by Tel1 and Mec1 is unknown. RESULTS: To identify all putative SCD-containing proteins, we analyzed the distribution of S/T-Q motifs within verified Tel1/Mec1 targets and arrived at a unifying SCD definition of at least 3 S/T-Q within a stretch of 50 residues. This new SCD definition was used in a custom bioinformatics pipeline to generate a census of SCD-containing proteins in both yeast and human. In yeast, 436 proteins were identified, a significantly larger number of hits than were expected by chance. These SCD-containing proteins did not distribute equally across GO-ontology terms, but were significantly enriched for those involved in processes related to the DDR. We also found a significant enrichment of proteins involved in telophase and cytokinesis, protein transport and endocytosis suggesting possible novel Tel1/Mec1 targets in these pathways. In the human proteome, a wide range of similar proteins were identified, including homologs of some SCD-containing proteins found in yeast. This list also included high concentrations of proteins in the Mediator, spindle pole body/centrosome and actin cytoskeleton complexes. CONCLUSIONS: Using a bioinformatic approach, we have generated a census of SCD-containing proteins that are involved not only in known DDR pathways but several other pathways under Tel1/Mec1 control suggesting new putative targets for these kinases.
Assuntos
Glutamina , Peptídeos e Proteínas de Sinalização Intracelular/química , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Proteínas Serina-Treonina Quinases/química , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas de Saccharomyces cerevisiae/química , Proteínas de Saccharomyces cerevisiae/metabolismo , Serina , Treonina , Motivos de Aminoácidos , Biologia Computacional , Humanos , Ligação Proteica , Estrutura Terciária de Proteína , Saccharomyces cerevisiae/metabolismoRESUMO
Aberrant RNA splicing is thought to play a key role in tumorigenesis. The assessment of its specific contributions is limited by the complexity of information derived from genome-wide array-based approaches. We describe how performing splicing factor-specific comparisons using both tumor and cell line data sets may more readily identify physiologically relevant tumor-specific splicing events. Affymetrix exon array data derived from glioblastoma (GBM) tumor samples with defined polypyrimidine tract-binding protein 1 (PTBP1) levels were compared with data from U251 GBM cells with and without PTBP1 knockdown. This comparison yielded overlapping gene sets that comprised only a minor fraction of each data set. The identification of a novel GBM-specific splicing event involving the USP5 gene led us to further examine its role in tumorigenesis. In GBM, USP5 generates a shorter isoform 2 through recognition of a 5' splice site within exon 15. Production of the USP5 isoform 2 was strongly correlated with PTBP1 expression in GBM tumor samples and cell lines. Splicing regulation was consistent with the presence of an intronic PTBP1 binding site and could be modulated through antisense targeting of the isoform 2 splice site to force expression of isoform 1 in GBM cells. The forced expression of USP5 isoform 1 in two GBM cell lines inhibited cell growth and migration, implying an important role for USP5 splicing in gliomagenesis. These results support a role for aberrant RNA splicing in tumorigenesis and suggest that changes in relatively few genes may be sufficient to drive the process.
Assuntos
Processamento Alternativo , Endopeptidases/genética , Regulação Neoplásica da Expressão Gênica , Glioblastoma/genética , Ribonucleoproteínas Nucleares Heterogêneas/metabolismo , Proteína de Ligação a Regiões Ricas em Polipirimidinas/metabolismo , Sequência de Bases , Sítios de Ligação , Linhagem Celular Tumoral , Movimento Celular , Proliferação de Células , Éxons , Técnicas de Silenciamento de Genes , Glioblastoma/metabolismo , Ribonucleoproteínas Nucleares Heterogêneas/genética , Humanos , Dados de Sequência Molecular , Proteína de Ligação a Regiões Ricas em Polipirimidinas/genética , Isoformas de Proteínas/genéticaRESUMO
Point mutations of EHMT1 or deletions and duplications of chromosome 9q34.3 are found in patients with variable neurologic and developmental disorders. Here, we present a child with congenital cataract, developmental and speech delay who developed a metastatic ganglioglioma with progression to anaplastic astrocytoma. Molecular analysis identified a novel constitutional tandem duplication in 9q34.3 with breakpoints in intron 1 of TRAF2 and intron 16 of EHMT1 generating a fusion transcript predicted to encode a truncated form of EHMT1. The ganglioglioma showed complex chromosomal aberrations with further duplication of the dup9q34. Thus, this unique tandem 9q34.3 duplication may impact brain tumor formation.
Assuntos
Duplicação Cromossômica , Cromossomos Humanos Par 9 , Ganglioglioma/genética , Histona-Lisina N-Metiltransferase/genética , Pré-Escolar , Feminino , Humanos , Fator 2 Associado a Receptor de TNF/genéticaRESUMO
Polypyrimidine tract-binding protein 1 (PTBP1) is a multi-functional RNA-binding protein that is aberrantly overexpressed in glioma. PTBP1 and its brain-specific homologue polypyrimidine tract-binding protein 2 (PTBP2) regulate neural precursor cell differentiation. However, the overlapping and non-overlapping target transcripts involved in this process are still unclear. To determine why PTBP1 and not PTBP2 would promote glial cell-derived tumours, both PTBP1 and PTBP2 were knocked down in the human glioma cell lines U251 and LN229 to determine the role of these proteins in cell proliferation, migration, and adhesion. Surprisingly, removal of both PTBP1 and PTBP2 slowed cell proliferation, with the double knockdown having no additive effects. Decreased expression of both proteins individually and in combination inhibited cell migration and increased adhesion of cells to fibronectin and vitronectin. A global survey of differential exon expression was performed following PTBP1 knockdown in U251 cells using the Affymetrix Exon Array to identify PTBP1-specific splicing targets that enhance gliomagenesis. In the PTBP1 knockdown, previously determined targets were unaltered in their splicing patterns. A single gene, RTN4 (Nogo) had significantly enhanced inclusion of exon 3 when PTBP1 was removed. Overexpression of the splice isoform containing exon 3 decreased cell proliferation to a similar degree as the removal of PTBP1. These results provide the first evidence that RNA-binding proteins affect the invasive and rapid growth characteristics of glioma cell lines. Its actions on proliferation appear to be mediated, in part, through alternative splicing of RTN4.
Assuntos
Glioma/patologia , Ribonucleoproteínas Nucleares Heterogêneas/fisiologia , Proteínas de Neoplasias/fisiologia , Proteínas do Tecido Nervoso/fisiologia , Proteína de Ligação a Regiões Ricas em Polipirimidinas/fisiologia , Citoesqueleto de Actina/patologia , Processamento Alternativo/fisiologia , Adesão Celular/fisiologia , Movimento Celular/fisiologia , Proliferação de Células , Éxons/genética , Regulação Neoplásica da Expressão Gênica , Técnicas de Silenciamento de Genes/métodos , Glioma/genética , Glioma/metabolismo , Ribonucleoproteínas Nucleares Heterogêneas/genética , Humanos , Proteínas da Mielina/biossíntese , Proteínas da Mielina/genética , Proteínas do Tecido Nervoso/genética , Proteínas Nogo , Proteína de Ligação a Regiões Ricas em Polipirimidinas/genética , Células Tumorais CultivadasRESUMO
Following disturbances to postural stability, balance recovery reactions are evoked by numerous sensory inputs and characterized by motor reactions involving different patterns of activity, depending on postural task conditions. It remains unknown whether well-documented cortical responses to instability share common spatio-temporal characteristics, despite variations in the sensory, motor, and postural components of the reactions. The objective was to explore the spatio-temporal profile of cortical potentials evoked by instability requiring either upper- or lower-limb compensatory responses. The hypothesis that upper- and lower-limb balance-correcting reactions are associated with evoked cortical potentials (N1, P2) featuring similar spatio-temporal characteristics was tested by inducing postural perturbations in seated (SIT) or standing (STAND) positions. For both conditions, N1 amplitude was greatest at FCz, with no significant differences in the timing of N1 peak (SIT: 142.4+/-7.95ms; STAND: 148.4+/-4.10ms) or N1 amplitude (SIT: 37.16+/-6.99microV; STAND: 39.08+/-4.51microV). The amplitude of the P2 potential (measured at CPz) was significantly larger in the STAND condition (37.87+/-6.14microV) than in the SIT (23.66+/-6.21microV) condition. Significant differences in P2 peak time between tasks were absent (SIT: 319.9+/-11.45ms; STAND: 322.7+/-7.61ms). Though differences in the amplitude of components of evoked potentials may reflect the extent of cortical involvement in different aspects of postural control, similarities in the spatio-temporal components of cortical potentials between tasks reflects generalizable cortical processing of unexpected stimuli independent of the sensory, motor, or postural aspects of the response.
Assuntos
Potenciais Evocados/fisiologia , Córtex Motor/fisiologia , Movimento/fisiologia , Equilíbrio Postural/fisiologia , Propriocepção/fisiologia , Córtex Somatossensorial/fisiologia , Adaptação Fisiológica/fisiologia , Adulto , Eletroencefalografia , Eletromiografia , Retroalimentação/fisiologia , Feminino , Humanos , Masculino , Contração Muscular/fisiologia , Estimulação Física , Tempo de Reação/fisiologia , Fatores de Tempo , Adulto JovemRESUMO
BACKGROUND: Tumor-predominant splice isoforms were identified during comparative in silico sequence analysis of EST clones, suggesting that global aberrant alternative pre-mRNA splicing may be an epigenetic phenomenon in cancer. We used an exon expression array to perform an objective, genome-wide survey of glioma-specific splicing in 24 GBM and 12 nontumor brain samples. Validation studies were performed using RT-PCR on glioma cell lines, patient tumor and nontumor brain samples. RESULTS: In total, we confirmed 14 genes with glioma-specific splicing; seven were novel events identified by the exon expression array (A2BP1, BCAS1, CACNA1G, CLTA, KCNC2, SNCB, and TPD52L2). Our data indicate that large changes (> 5-fold) in alternative splicing are infrequent in gliomagenesis (< 3% of interrogated RefSeq entries). The lack of splicing changes may derive from the small number of splicing factors observed to be aberrantly expressed. CONCLUSION: While we observed some tumor-specific alternative splicing, the number of genes showing exclusive tumor-specific isoforms was on the order of tens, rather than the hundreds suggested previously by in silico mining. Given the important role of alternative splicing in neural differentiation, there may be selective pressure to maintain a majority of splicing events in order to retain glial-like characteristics of the tumor cells.
Assuntos
Processamento Alternativo , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/metabolismo , Glioblastoma/genética , Glioblastoma/metabolismo , Precursores de RNA/genética , Precursores de RNA/metabolismo , RNA Neoplásico/genética , RNA Neoplásico/metabolismo , Sequência de Bases , Linhagem Celular Tumoral , Primers do DNA/genética , Epigênese Genética , Éxons , Perfilação da Expressão Gênica , Glioma/genética , Glioma/metabolismo , Humanos , Análise de Sequência com Séries de Oligonucleotídeos , Receptor Tipo 1 de Fator de Crescimento de Fibroblastos/genética , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
INTRODUCTION: Although multiple predispositions to hematologic malignancies exist, evaluations for hereditary cancer syndromes (HCS) are underperformed by most hematologist/oncologists. Criteria for initiating HCS evaluation are poorly defined, and results of genetic testing for hereditary hematologic malignancies have not been systematically reported. PATIENTS AND METHODS: From April 2014 to August 2015, 67 patients were referred to the Hereditary Hematologic Malignancy Clinic (HHMC). Referral reasons included (1) bone marrow failure or myelodysplastic syndrome in patients ≤ 50 years, (2) evaluation for germ-line inheritance of identified RUNX1, GATA2, or CEBPA mutations on targeted next-generation sequencing panels, and (3) strong personal and/or family history of malignancy. Cultured skin fibroblasts were utilized for germ-line DNA in all patients with hematologic malignancy. RESULTS: Eight patients (12%) were clinically diagnosed with a HCS: 4 patients with RUNX1-related familial platelet disorder (FPD)/acute myeloid leukemia (AML), and 1 patient each with dyskeratosis congenita, Fanconi anemia, germ-line DDX41, and Li-Fraumeni syndrome (LFS). Two patients with concern for FPD/AML and LFS, respectively, had RUNX1 and TP53 variants of unknown significance. Additionally, 4 patients with prior HCS diagnosis (1 LFS, 3 FPD/AML) were referred for further evaluation and surveillance. CONCLUSION: In this HHMC-referred hematologic malignancy cohort, HCS was confirmed in 12 patients (18%). HCS identification provides insight for improved and individualized treatment, as well as screening/surveillance opportunities for family members. The HHMC has facilitated HCS diagnosis; with increased clinical awareness of hematologic malignancy predisposition syndromes, more patients who may benefit from evaluation can be identified. Mutation panels intended for prognostication may provide increased clinical suspicion for germ-line testing.
Assuntos
Família/psicologia , Predisposição Genética para Doença/psicologia , Neoplasias Hematológicas/epidemiologia , Síndromes Neoplásicas Hereditárias/epidemiologia , Pacientes/psicologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais , Feminino , Aconselhamento Genético , Mutação em Linhagem Germinativa , Neoplasias Hematológicas/diagnóstico , Neoplasias Hematológicas/genética , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Masculino , Pessoa de Meia-Idade , Síndromes Neoplásicas Hereditárias/diagnóstico , Síndromes Neoplásicas Hereditárias/genética , Linhagem , Encaminhamento e Consulta , Texas , Fluxo de Trabalho , Adulto JovemRESUMO
Multiple synchronous lung cancers (MSLCs) present a clinical dilemma as to whether individual tumours represent intrapulmonary metastases or independent tumours. In this study we analyse genomic profiles of 15 lung adenocarcinomas and one regional lymph node metastasis from 6 patients with MSLC. All 15 lung tumours demonstrate distinct genomic profiles, suggesting all are independent primary tumours, which are consistent with comprehensive histopathological assessment in 5 of the 6 patients. Lung tumours of the same individuals are no more similar to each other than are lung adenocarcinomas of different patients from TCGA cohort matched for tumour size and smoking status. Several known cancer-associated genes have different mutations in different tumours from the same patients. These findings suggest that in the context of identical constitutional genetic background and environmental exposure, different lung cancers in the same individual may have distinct genomic profiles and can be driven by distinct molecular events.
Assuntos
Adenocarcinoma/genética , Heterogeneidade Genética , Genoma Humano/genética , Neoplasias Pulmonares/genética , Adenocarcinoma/patologia , Perfilação da Expressão Gênica/métodos , Regulação Neoplásica da Expressão Gênica , Humanos , Neoplasias Pulmonares/patologia , Mutação , Análise de Sequência de DNA/métodosRESUMO
Clinical cancer genetic susceptibility analysis typically proceeds sequentially, beginning with the most likely causative gene. The process is time consuming and the yield is low, particularly for families with unusual patterns of cancer. We determined the results of in parallel mutation analysis of a large cancer-associated gene panel. We performed deletion analysis and sequenced the coding regions of 45 genes (8 oncogenes and 37 tumor suppressor or DNA repair genes) in 48 childhood cancer patients who also (i) were diagnosed with a second malignancy under age 30, (ii) have a sibling diagnosed with cancer under age 30, and/or (iii) have a major congenital anomaly or developmental delay. Deleterious mutations were identified in 6 of 48 (13%) families, 4 of which met the sibling criteria. Mutations were identified in genes previously implicated in both dominant and recessive childhood syndromes, including SMARCB1, PMS2, and TP53. No pathogenic deletions were identified. This approach has provided efficient identification of childhood cancer susceptibility mutations and will have greater utility as additional cancer susceptibility genes are identified. Integrating parallel analysis of large gene panels into clinical testing will speed results and increase diagnostic yield. The failure to detect mutations in 87% of families highlights that a number of childhood cancer susceptibility genes remain to be discovered.
Assuntos
Predisposição Genética para Doença , Neoplasias/epidemiologia , Neoplasias/genética , Adolescente , Adulto , Algoritmos , Criança , Análise Mutacional de DNA , Reparo do DNA , Dosagem de Genes , Genes Dominantes , Genes Recessivos , Genes Supressores de Tumor , Humanos , Imunoprecipitação , Modelos Genéticos , Mutação , Oncogenes , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tumor Rabdoide/genéticaRESUMO
Previous work has revealed pre-perturbation cortical activity linked to predictably-timed perturbations to upright stability. Because individuals rely on the ability to anticipate perturbations for independent mobility, we sought to determine whether perturbation-evoked cortical potentials elicited by voluntarily-initiated external perturbations were dissociable from those elicited by externally-cued perturbations. Postural instability was evoked under three experimental conditions: cued external perturbations (EXT-CUE), cued self-initiated perturbations (SELF-CUE), and un-cued self-initiated perturbations (SELF-NO CUE). All conditions were characterized by comparable pre-perturbation slow-wave potentials initiated 1536.83+/-44.94 ms prior to perturbation onset, measuring 11.24+/-0.94 microV in amplitude. There were no differences in pre-perturbation cortical activity across tasks. Post-perturbation N1 potentials were also evoked, reaching peak amplitude at 132.63+/-3.40 ms following perturbation onset. The potentials were significantly larger in the EXT-CUE (17.08+/-2.99 microV) condition than both the SELF-CUE (11.98+/-2.53 microV) and SELF-NO CUE conditions (9.24+/-1.79 microV). There were no significant differences across tasks for measures of tibialis anterior muscle activity prior to or following perturbation onset, nor were there significant differences in centre of pressure excursion amplitude across tasks. This study highlights that despite using different mechanisms to initiate temporally predictable perturbations to upright stability, pre-perturbation cortical events with similar spatio-temporal characteristics and magnitude are evoked, signalling consistency in the cortical processes that optimize compensatory postural responses which are independent from the cues that inform the onset of postural instability. These findings enhance the understanding of cortical involvement in postural control.
Assuntos
Córtex Cerebral/fisiologia , Processos Mentais/fisiologia , Equilíbrio Postural/fisiologia , Adulto , Análise de Variância , Sinais (Psicologia) , Eletroencefalografia , Eletromiografia , Potenciais Evocados , Feminino , Humanos , Masculino , Músculo Esquelético/fisiologia , Fatores de Tempo , Adulto JovemRESUMO
Polypyrimidine tract binding protein (PTB) is expressed in developing mammalian astrocytes, absent in mature adult astrocytes, and aberrantly elevated in gliomas. It is unclear whether PTB is a coincidental marker of tumor progression or a significant mediator of tumorigenesis. In developing Drosophila, the absence of the PTB homolog, hephaestus, results in increased Notch activity. Since Notch is a well-known inducer of glial cell fate, we determined whether overexpression of PTB in glial cell tumors provides a selective growth advantage by inhibiting activated Notch (Notch1IC)-mediated differentiation. To do this, we performed an immunohistochemical analysis for expression of PTB, activated Notch1 (Notch1IC), Hes1 (a Notch target), and GFAP on an extensive human tissue microarray that included 246 gliomas, 10 gliosarcomas, and 10 normal brains. Statistically significant PTB overexpression was seen in all glioma grades, with the highest increase in grade IV tumors. Notch1IC was also abnormally expressed in gliomas except in a subset of grade IV tumors in which it was absent. This decrease in Notch1IC was not associated with increased PTB expression. We conclude that PTB, and Notch1 serve as independent and functionally unlinked markers of glioma progression.